Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Gossamer Bio (GOSS) Invested Capital (2022 - 2025)

Historic Invested Capital for Gossamer Bio (GOSS) over the last 4 years, with Q3 2025 value amounting to -$82.3 million.

  • Gossamer Bio's Invested Capital fell 13274.71% to -$82.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$82.3 million, marking a year-over-year decrease of 13274.71%. This contributed to the annual value of $227.0 million for FY2024, which is 1247.11% down from last year.
  • As of Q3 2025, Gossamer Bio's Invested Capital stood at -$82.3 million, which was down 13274.71% from -$46.1 million recorded in Q2 2025.
  • Gossamer Bio's Invested Capital's 5-year high stood at $301.0 million during Q3 2023, with a 5-year trough of -$82.3 million in Q3 2025.
  • Its 4-year average for Invested Capital is $171.4 million, with a median of $223.5 million in 2024.
  • In the last 5 years, Gossamer Bio's Invested Capital surged by 10891.83% in 2024 and then tumbled by 13274.71% in 2025.
  • Over the past 4 years, Gossamer Bio's Invested Capital (Quarter) stood at $207.8 million in 2022, then grew by 24.82% to $259.4 million in 2023, then fell by 12.47% to $227.0 million in 2024, then plummeted by 136.27% to -$82.3 million in 2025.
  • Its last three reported values are -$82.3 million in Q3 2025, -$46.1 million for Q2 2025, and -$6.2 million during Q1 2025.